In this 1:2:1 podcast, host Paul Costello talks with Eugenia Zukerman, who is living with Alzheimer's disease and has a new book of poetry.
People with a mutation in an enzyme that breaks down alcohol may be at a higher risk for developing Alzheimer's disease, new research suggests.
This In the Spotlight Q&A features Garam Kim, a former professional violinist pursuing a PhD in neurosciences at Stanford.
A new discovery could provide a way of detecting Parkinson's disease in its earliest stages, before symptoms start. And it could accelerate the development of …
An article in Stanford Medicine magazine examines how Stanford Health Care cut half an hour off its stroke treatment time, helping patients.
Stanford scientists have conducted a proof-of-concept experiment in mice that shows they can use blood stem cells to treat a severe brain disease.
In this final piece on aspirin for prevention of heart attack and stroke, Randall Stafford explains factors for doctors and patients to consider.
In this installment of "Aspirin for prevention," physician-researcher Randall Stafford provides tips to calculate the risk of heart disease or stroke, to inform decisions about taking aspirin preventatively.
Selectively subduing a set of cells that migrate to the brain after a stroke occurs could meaningfully treat the stroke even days later.
At the second annual Diversity & Inclusion Forum, attendees brainstormed how to help underrepresented groups feel like they belong in medicine.
In this 1:2:1 podcast, Greg Albers, director of the Stanford Stroke Center, joins host Paul Costello in conversation about the latest in stroke research.
Stanford researchers are collaborating to develop a vibrating glove that could improve hand function following a stroke if worn for several hours a day.
Brain cells called microglia keep brains young by eliminating accumulations of protein debris. But their garbage-colllection ability fades with age.
While different Asian groups vary in their risk for heart disease and stroke, all Asian groups are more likely to die early of a stroke than whites.
Scientists studying cell death are working to understand how the body protects itself from disease and use that information to form better treatments.
A pattern of inflammatory activity in circulating blood cells just two days after a stroke predicts the loss of substantial mental acuity a full year later.
